Primary prevention of dementia
Symptomatic treatments that work by enhancing neurotransmitter function have been available for several years, and are generally accepted as being modestly beneficial in about 50% of those for whom they are prescribed. Disease-modifying drugs that may prevent or retard neuronal deterioration are bei...
第一著者: | Wilcock, G |
---|---|
フォーマット: | Book section |
出版事項: |
2004
|
類似資料
-
Methodological issues in primary prevention trials for neurodegenerative dementia.
著者:: Andrieu, S, 等
出版事項: (2009) -
Dementia with Lewy bodies.
著者:: Wilcock, G
出版事項: (2003) -
The ageing brain and dementia.
著者:: Wilcock, G
出版事項: (1981) -
Memantine for the treatment of dementia.
著者:: Wilcock, G
出版事項: (2003) -
A review of dementia.
著者:: Wilcock, G
出版事項: (1982)